Prostate Cancer

One radiation oncologist describes the advantages of MRI-guided SBRT when treating patients with prostate cancer.

While adherence to germline testing has been found to be low, one expert explained why tests findings could matter to patients.

As part of our “Speaking Out” video series, we look at the association between prostate cancer and mental health.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

During my "watch and wait" time for prostate cancer, I spend this time wisely on things like attending writing webinars.

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.

As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.

From the NBA’s Alonzo Mourning opening up about his prostate surgery to an actor from “Felicity” dying of cancer, here’s what is happening in the oncology space this week.

Two years of postsurgical androgen deprivation therapy resulted in a 10-year metastasis-free survival rate of nearly 80%.

Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.

From Michael Richards revealing his prostate cancer diagnosis to MLB Hall-of-Famer Ryne Sandberg being cancer-free, here’s what’s happening in the oncology space this week.

Whole-pelvic radiation conferred a 67% lower risk of all-cause mortality among patients younger than 65 with unfavorable-risk prostate cancer.

Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.

From Olivia Munn opening up about undergoing a hysterectomy and egg retrieval to Michael McDonald’s learned lesson after his wife’s cancer, here’s what’s going on in the oncology space this week.

The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.

When I found out my PSA levels were rising, I was so overwhelmed moments leading up to my telehealth session with my urologist.

Treatment with a certain radiation therapy worsens quality of life in patients with prostate cancer. An expert explains ways to mitigate side effects.

From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.

Topline data has been released from a trial of antibody-drug conjugate FG-3246 for patients with pretreated, metastatic castration-resistant prostate cancer.

Compared to other treatments, patients’ testosterone levels return to baseline levels faster following treatment with Orgovyx.

Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D.

When experiencing loss, always look forward and have hope.

My prostate cancer has come back and stronger, but so have I.

Researchers on a phase 1/2 trial provided the first dose of gotistobart plus Pluvicto to a specific patient population with prostate cancer.

A UCLA neurobiology professor and prostate cancer survivor discuss using artificial intelligence to map his disease and inform treatment decisions.